Access to medicine index 2010

"The Index 2010 report covers 27 companies, comprising 20 originators and seven generics manufacturers. The ranking isand based on 106 indicators that measure activities across four strategic and seven technical areas. The research and analysis for the Index 2010 was conducted by RiskMetrics Group..."

The Index 2010 | Access to Medicine Index

CME and Corporate Relationships

Misgivings Grow Over Corporate Role in Keeping Doctors Current - NYTimes.com

Pew: How the Press (Failed /) Covered Health Care Reform

How the Press Covered Health Care Reform - Pew Research Center

Education as the Engine for Globalization

The Rise of the Global University: 5 New Tensions - Commentary - The Chronicle of Higher Education

Further along the road of medicalizing life ...

Maker Plays Up Sexual Disorder, With a Pill in Waiting - NYTimes.com

But is it only animal cruety?

If an aspect is preying on the weak, other early relationships permit the expression of this behavior.


The Animal-Cruelty Syndrome - NYTimes.com

A long fall from the Tylenol recall

Johnson and Johnson Seen as Uncooperative on Recall Inquiry - NYTimes.com

Donald Rumsfeld's Old Europe Tackles Modern Finance

FT.com / Brussels / Business regulation - Brussels to reveal rating agency plans

When your friends are few, rely on perspective to provide some shelter

FT.com / FT Trading Room / Regulation - Rating agencies face fresh questions

Who Knew Renting a Congressman Could Be So Cheap?

Assuming that there isn't invisible ink in the oath of office that commits members of Congress to oppose the public good, I can only assume that it doesn't take much to capture their hearts and minds ...

Halliburton campaign donations spike - Jake Sherman - POLITICO.com

In the spirit of who judges the judges ...

FT.com / US & Canada - Buffett bats off criticism of Moody’s

Telemedicine - at the point of no return?

Healing by 2-Way Video - The Rise of Telemedicine - NYTimes.com

How do the business and the clinical model converge for the benefit of all patients?

Are Fines Sufficient Disincentives or a Cost of Doing Business?

Curbing Drug-Company Abuses: Are Fines Enough?

Curbing Drug-Company Abuses: Are Fines Enough?